SCHEDULE 13D

Company

Outlook Therapeutics, Inc.

Filed

September 18, 2017

Accession Number

0000947871-17-000736

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →